Ionis Pharmaceuticals, Inc. (IONS)
62.03
+2.29
(+3.83%)
USD |
NASDAQ |
Aug 24, 16:00
61.98
-0.05
(-0.08%)
After-Hours: 20:00
Ionis Pharmaceuticals 1 Year Total Returns (Daily) : 38.18% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 38.18% |
| August 20, 2026 | 37.26% |
| August 19, 2026 | 43.13% |
| August 18, 2026 | 37.28% |
| August 17, 2026 | 33.92% |
| August 14, 2026 | 33.58% |
| August 13, 2026 | 29.63% |
| August 12, 2026 | 36.51% |
| August 11, 2026 | 35.70% |
| August 10, 2026 | 36.74% |
| August 07, 2026 | 37.78% |
| August 06, 2026 | 33.92% |
| August 05, 2026 | 25.88% |
| August 04, 2026 | 26.74% |
| August 03, 2026 | 26.63% |
| July 31, 2026 | 20.45% |
| July 30, 2026 | 22.85% |
| July 29, 2026 | 30.28% |
| July 28, 2026 | 34.32% |
| July 27, 2026 | 32.47% |
| July 24, 2026 | 34.16% |
| July 23, 2026 | 31.83% |
| July 22, 2026 | 28.75% |
| July 21, 2026 | 28.50% |
| July 20, 2026 | 26.80% |
| Date | Value |
|---|---|
| July 17, 2026 | 28.98% |
| July 16, 2026 | 27.78% |
| July 15, 2026 | 30.31% |
| July 14, 2026 | 29.10% |
| July 13, 2026 | 35.99% |
| July 10, 2026 | 37.45% |
| July 09, 2026 | 50.06% |
| July 08, 2026 | 104.3% |
| July 07, 2026 | 106.6% |
| July 06, 2026 | 93.44% |
| July 02, 2026 | 87.66% |
| July 01, 2026 | 98.27% |
| June 30, 2026 | 100.7% |
| June 29, 2026 | 102.7% |
| June 26, 2026 | 104.1% |
| June 25, 2026 | 95.85% |
| June 24, 2026 | 93.04% |
| June 23, 2026 | 101.7% |
| June 22, 2026 | 102.9% |
| June 18, 2026 | 100.3% |
| June 17, 2026 | 105.6% |
| June 16, 2026 | 107.4% |
| June 15, 2026 | 107.8% |
| June 12, 2026 | 105.7% |
| June 11, 2026 | 104.0% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Alnylam Pharmaceuticals, Inc. | -49.48% |
| Biogen, Inc. | 55.82% |
| BridgeBio Pharma, Inc. | 62.25% |
| Vertex Pharmaceuticals, Inc. | 37.89% |
| Arrowhead Pharmaceuticals, Inc. | 319.8% |